阿斯利康

?? ?????????????????? ?????? ?????? ??????????! Construction continues apace at One Helix, AstraZeneca's R&D Cell Therapy facility in the Netherlands, marking an exciting chapter in this project. Recently, a ceremonial raising of the flags celebrated progress on this cutting-edge biotech research facility, developed by Breakthrough Properties and designed by UNStudio. Specifically tailored to support AstraZeneca's Cell Therapy R&D, the site will play a vital role in achieving our Scope 1 and 2 decarbonisation targets and is designed to earn a BREEAM Outstanding rating. ? Sustainability is embedded in every aspect of One Helix. Geothermal heating and cooling, solar energy, and the use of biobased materials set a new benchmark for responsible construction. With its energy-positive design, the building reinforces our commitment to environmental progress and our path towards net zero. ? Watch the video below for a first look at this extraordinary project.

In Cleusa’s rural community in S?o Paulo, a local initiative played a crucial role in the early diagnosis and treatment of her lung cancer. The initiative focuses on promoting lung health equity by improving screening and early detection of lung diseases in underserved communities. In a series presented by the Union for International Cancer Control (UICC) and produced for AstraZeneca by BBC StoryWorks , we share the experiences of people like Cleusa, who are changing the perception of what it means to be diagnosed with cancer. Learn how access to screening and early treatment helped Cleusa spend more time with the people she loves: https://learn.az/6041tKLJJ #LungCancerAwarenessMonth #HealthEquity #RewritingCancer

Chronic kidney disease (CKD) is a growing global health crisis impacting patients, caregivers, healthcare systems, economies, and even the environment—but change is possible. In partnership with the Global Patient Alliance for Kidney Health we are urging policymakers to elevate CKD on the global health agenda and prioritise early detection, diagnosis and access to treatment and care. Let’s make the change together. Sign up to stay informed and join us in transforming kidney health: https://learn.az/6040sCeg0 #ForKidneyHealth

By embedding sustainability into everything we do – from the lab to the patient – we’re pushing the boundaries of what science can do to deliver more equitable, resilient and net zero healthcare. Here are seven ways we’re harnessing the power of sustainable science. Explore our sustainable science hub to learn more: https://learn.az/6047WDGJR #WhatScienceCanDo

As leaders in respiratory, our ambition is to transform patient outcomes, while also reducing the carbon footprint of our medicines. That is why we are pleased to share that our industry first, regulatory submission for our inhaled devices using a next-generation propellant with near-zero global warming potential has been accepted by the European Medicines Agency. Transitioning our pMDI portfolio to our next-generation propellant is a key component of our Ambition Zero Carbon strategy. Learn more about our progress in decarbonising respiratory care. #WhatScienceCanDo

The health of our people, society and planet are deeply interconnected. Tackling climate change, advancing health equity and supporting resilient health systems are not just goals—they're necessities. As the world continues to face these complicated challenges, it's clear that we need to act. Science empowers us to understand these complexities and drive improvements for both people and our planet. Through innovation, collaboration and a focus on sustainability, we can create a healthier future for all. Let's work together to make this vision a reality. Join the conversation on building a healthier future. Together, we can make a big difference. https://learn.az/6044sUrAs #WhatScienceCanDo

Congratulations to Iskra Reic, Executive Vice President, Vaccines & Immune Therapies, for being named one of Fierce Pharma's Fiercest Women in Life Sciences 2024. With over 20 years at AstraZeneca and as a Senior Executive Team member since 2017, Iskra’s visionary leadership, has fueled breakthrough vaccines and antibodies, protecting the patients globally from serious viral and bacterial infections. Her dedication to innovation, mentorship and long-term business growth continues to inspire us all. We couldn’t be prouder. Congratulations, Iskra! #WhatScienceCanDo

Millions of people suffer from COPD, a chronic lung disease caused by indoor and outdoor air pollution, second-hand smoke, or smoking. This places a heavy burden on individuals and the planet, yet stigma prevents people from seeking care. Greater understanding can encourage screenings, improve care, and save lives. It's time for governments to prioritise COPD and mortality reduction by developing and funding national respiratory strategies. Be part of the change: https://learn.az/6047s6dM3 #WorldCOPDDay #SpeakUpforCOPD

Our Top 5 position in the Access to Medicine Foundation's latest Access to Medicine Index, reflects the efforts of our colleagues across AstraZeneca to increase equitable and affordable access to life-changing treatments. We are pleased to see the progress made across our sector and remain committed to working with governments, policymakers, healthcare providers and communities, to strengthen health systems and improve equitable and early disease detection, diagnosis and treatment for patients. Find out more: https://learn.az/6043soMZL #AccesstoMedicine

Our goal of eliminating cancer as a cause of death is ambitious and having leaders who champion the cause will help us make it a reality. Please welcome Bob Li to our Oncology team as Global Head of Medical Affairs. Bob will lead the team’s efforts to uncover gaps in scientific evidence and enhance the patient experience, integrating these insights to help advance clinical practice. With more than 15 years of global experience in clinical research and as a thoracic oncologist, he will bring invaluable perspectives as we work to improve care and outcomes for patients. Discover more: https://learn.az/6043s9CZ1